| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4272009 | The Journal of Sexual Medicine | 2009 | 4 Pages |
Abstract
PDE5 dysregulation seems to be an underline pathogenetic mechanism of thalassemia intermedia-associated priapism. It appears that PDE5is might have a role in the clinical management of such patients and their preventive efficacy warrants further testing in clinical trials. Tzortzis V, Mitrakas L, Gravas S, Mamoulakis C, Meissner A, Kyriakou D, and Melekos MD. Oral phosphodiesterase type 5 inhibitors alleviate recurrent priapism complicating thalassemia intermedia: A case report. J Sex Med 2009;6:2068-2071.
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Vassilios MD, PhD, Lampros MD, Stavros MD, PhD, Charalampos MD, PhD, Andreas MD, PhD, Despina MD, PhD, Michael D. MD, PhD,